Published in Arch Neurol on July 01, 2006
Introduction to behavioral addictions. Am J Drug Alcohol Abuse (2010) 3.22
Review. The neurobiology of pathological gambling and drug addiction: an overview and new findings. Philos Trans R Soc Lond B Biol Sci (2008) 2.40
Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain (2009) 2.35
The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol (2007) 2.22
Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease. Mayo Clin Proc (2009) 2.06
Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord (2009) 1.89
Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron (2010) 1.85
Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness. Psychopharmacology (Berl) (2007) 1.64
Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology (Berl) (2009) 1.62
Parkinson's disease: the quintessential neuropsychiatric disorder. Mov Disord (2011) 1.62
Decision-making during gambling: an integration of cognitive and psychobiological approaches. Philos Trans R Soc Lond B Biol Sci (2010) 1.46
Shared brain vulnerabilities open the way for nonsubstance addictions: carving addiction at a new joint? Ann N Y Acad Sci (2010) 1.46
Impulse control disorders and related behaviours (ICD-RBs) in Parkinson's disease patients: Assessment using "Questionnaire for impulsive-compulsive disorders in Parkinson's disease" (QUIP). Ann Indian Acad Neurol (2015) 1.43
Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease. J Neurol Neurosurg Psychiatry (2007) 1.42
Subthalamic nucleus stimulation influences expression and suppression of impulsive behaviour in Parkinson's disease. Brain (2010) 1.37
Cognitive enhancement by drugs in health and disease. Trends Cogn Sci (2010) 1.35
Reward signals, attempted suicide, and impulsivity in late-life depression. JAMA Psychiatry (2013) 1.30
The roles of dopamine and serotonin in decision making: evidence from pharmacological experiments in humans. Neuropsychopharmacology (2010) 1.28
Dopamine agonist increases risk taking but blunts reward-related brain activity. PLoS One (2008) 1.27
Long-term follow-up of impulse control disorders in Parkinson's disease. Mov Disord (2008) 1.27
Decreased ventral striatal activity with impulse control disorders in Parkinson's disease. Mov Disord (2010) 1.22
Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale. Mov Disord (2011) 1.19
Dopamine and impulse control disorders in Parkinson's disease. Ann Neurol (2008) 1.18
Suicidal and death ideation in Parkinson's disease. Mov Disord (2008) 1.17
Patient versus informant reporting of ICD symptoms in Parkinson's disease using the QUIP: validity and variability. Parkinsonism Relat Disord (2010) 1.14
Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. Sleep (2010) 1.13
Nonmotor symptoms in Parkinson's disease in 2012: relevant clinical aspects. Parkinsons Dis (2012) 1.12
Steady-state assessment of impulsive choice in Lewis and Fischer 344 rats: between-condition delay manipulations. J Exp Anal Behav (2008) 1.11
Parkinson's disease-related disorders in the impulsive-compulsive spectrum. J Neurol (2008) 1.08
The risky business of dopamine agonists in Parkinson disease and impulse control disorders. Behav Neurosci (2011) 1.04
Prefrontal dopamine signaling and cognitive symptoms of Parkinson's disease. Rev Neurosci (2013) 1.03
Simultaneous blockade of dopamine and noradrenaline reuptake promotes disadvantageous decision making in a rat gambling task. Psychopharmacology (Berl) (2012) 1.02
Influence of conditioned reinforcement on the response-maintaining effects of quinpirole in rats. Behav Pharmacol (2009) 1.01
The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access. Addict Biol (2010) 0.98
Dopamine agonists and the suppression of impulsive motor actions in Parkinson disease. J Cogn Neurosci (2012) 0.98
Reward networks in the brain as captured by connectivity measures. Front Neurosci (2009) 0.98
Deep brain stimulation of nucleus accumbens region in alcoholism affects reward processing. PLoS One (2012) 0.97
Impulse control disorders following deep brain stimulation of the subthalamic nucleus in Parkinson's disease: clinical aspects. Parkinsons Dis (2011) 0.96
Pathological gambling and substance use disorders. Am J Drug Alcohol Abuse (2010) 0.96
The temptation of suicide: striatal gray matter, discounting of delayed rewards, and suicide attempts in late-life depression. Psychol Med (2011) 0.95
Current status of symptomatic medical therapy in Parkinson's disease. Neurotherapeutics (2008) 0.94
Pramipexole and compulsive masturbation. Psychiatry (Edgmont) (2007) 0.91
Reconceptualizing anhedonia: novel perspectives on balancing the pleasure networks in the human brain. Front Behav Neurosci (2015) 0.91
Improving response inhibition in Parkinson's disease with atomoxetine. Biol Psychiatry (2014) 0.91
Levodopa medication does not influence motor inhibition or conflict resolution in a conditional stop-signal task in Parkinson's disease. Exp Brain Res (2011) 0.90
Effects of pramipexole on impulsive choice in male wistar rats. Exp Clin Psychopharmacol (2010) 0.90
Management of sexual dysfunction in Parkinson's disease. Ther Adv Neurol Disord (2011) 0.90
Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome. BMC Neurol (2011) 0.89
Binge eating in Parkinson's disease: prevalence, correlates and the contribution of deep brain stimulation. J Neuropsychiatry Clin Neurosci (2011) 0.88
Prospective cohort study of impulse control disorders in Parkinson's disease. Mov Disord (2013) 0.88
Dopamine-induced nonmotor symptoms of Parkinson's disease. Parkinsons Dis (2011) 0.88
How central is dopamine to pathological gambling or gambling disorder? Front Behav Neurosci (2013) 0.87
Dopamine agonists rather than deep brain stimulation cause reflection impulsivity in Parkinson's disease. J Parkinsons Dis (2013) 0.87
Available and emerging treatments for Parkinson's disease: a review. Drug Des Devel Ther (2011) 0.87
Impulsivity and apathy in Parkinson's disease. J Neuropsychol (2013) 0.87
Multiple modes of impulsivity in Parkinson's disease. PLoS One (2014) 0.87
Prevalence of hypersexual behavior in Parkinson's disease patients: Not restricted to males and dopamine agonist use. Int J Gen Med (2009) 0.86
Ventral striatal dopamine synthesis capacity is associated with individual differences in behavioral disinhibition. Front Behav Neurosci (2014) 0.84
Reward processing abnormalities in Parkinson's disease. Mov Disord (2011) 0.84
Targeting impulsivity in Parkinson's disease using atomoxetine. Brain (2014) 0.84
The role of dopamine in risk taking: a specific look at Parkinson's disease and gambling. Front Behav Neurosci (2014) 0.83
A short scale for evaluation of neuropsychiatric disorders in Parkinson's disease: first psychometric approach. J Neurol (2012) 0.83
Spectrum of addictions in Parkinson's disease: from dopamine dysregulation syndrome to impulse control disorders. J Neurol (2010) 0.82
Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy? Ther Adv Neurol Disord (2012) 0.82
Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists. J Clin Neurosci (2010) 0.82
Dopaminergic influences on emotional decision making in euthymic bipolar patients. Neuropsychopharmacology (2013) 0.82
The Iowa Gambling Task and the three fallacies of dopamine in gambling disorder. Front Psychol (2013) 0.82
Impulsive and compulsive behaviors in Parkinson's disease. Front Aging Neurosci (2014) 0.82
Dose dependent dopaminergic modulation of reward-based learning in Parkinson's disease. Neuropsychologia (2011) 0.81
Detecting associations between behavioral addictions and dopamine agonists in the Food & Drug Administration's Adverse Event database. J Behav Addict (2014) 0.81
Pharmacological evaluation of the adequacy of marble burying as an animal model of compulsion and/or anxiety. Behav Pharmacol (2011) 0.81
Diagnosis and treatment of impulse control disorders in patients with movement disorders. Ther Adv Neurol Disord (2013) 0.80
Altruistic punishment in patients with Parkinson's disease with and without impulsive behaviour. Neuropsychologia (2010) 0.80
Gambling disorder during dopamine replacement treatment in Parkinson's disease: a comprehensive review. Biomed Res Int (2014) 0.80
Impulse control disorders in Parkinson's disease: an overview from neurobiology to treatment. J Neurol (2014) 0.79
COMT and ANKK1 Genetics Interact With Depression to Influence Behavior Following Severe TBI: An Initial Assessment. Neurorehabil Neural Repair (2016) 0.79
Impulse control disorders in Parkinson's disease: background and update on prevention and management. Neurodegener Dis Manag (2012) 0.79
Update on the use of pramipexole in the treatment of Parkinson's disease. Neuropsychiatr Dis Treat (2008) 0.79
Study protocol: the JEU cohort study--transversal multiaxial evaluation and 5-year follow-up of a cohort of French gamblers. BMC Psychiatry (2014) 0.79
Modulation of habit formation by levodopa in Parkinson's disease. PLoS One (2011) 0.79
Pathological Gambling: Biological and Clinical Considerations. J Addict Med (2009) 0.79
Atomoxetine Enhances Connectivity of Prefrontal Networks in Parkinson's Disease. Neuropsychopharmacology (2016) 0.78
Sleep and impulsivity in Parkinson's disease. Parkinsonism Relat Disord (2013) 0.78
[The neurobiology of impulse control disorders]. Rev Bras Psiquiatr (2008) 0.78
Identifying the Basal Ganglia network model markers for medication-induced impulsivity in Parkinson's disease patients. PLoS One (2015) 0.78
Amantadine and cognitive flexibility: decision making in Parkinson's patients with severe pathological gambling and other impulse control disorders. Neuropsychiatr Dis Treat (2014) 0.77
Social behavioral changes in MPTP-treated monkey model of Parkinson's disease. Front Behav Neurosci (2015) 0.77
Impulse control disorders in Parkinson's disease. F1000 Med Rep (2009) 0.77
Impulse control disorders in patients with dopamine agonist-treated prolactinomas and nonfunctioning pituitary adenomas: a case-control study. Clin Endocrinol (Oxf) (2013) 0.77
Clinical characteristics of impulse control and repetitive behavior disorders in Parkinson's disease. J Neurol (2012) 0.77
Dopamine Selectively Modulates the Outcome of Learning Unnatural Action-Valence Associations. J Cogn Neurosci (2017) 0.76
Dissociable Effects of Dopamine on the Initial Capture and the Reactive Inhibition of Impulsive Actions in Parkinson's Disease. J Cogn Neurosci (2016) 0.76
Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy: Do Patients Share the Same Features? A Review. J Clin Psychopharmacol (2016) 0.76
Neural and behavioral substrates of subtypes of Parkinson's disease. Front Syst Neurosci (2013) 0.76
An eight component decision-making model for problem gambling: a systems approach to stimulate integrative research. J Gambl Stud (2011) 0.76
Comparison of frequencies of non motor symptoms in Indian Parkinson's disease patients on medical management versus deep brain stimulation: A case-control study. Iran J Neurol (2015) 0.76
The treatment of erectile dysfunction in patients with neurogenic disease. Transl Androl Urol (2016) 0.76
A combination of dopamine genes predicts success by professional Wall Street traders. PLoS One (2012) 0.76
Maladaptive reward-learning and impulse control disorders in patients with Parkinson's disease: a clinical overview and pathophysiology update. J Mov Disord (2014) 0.76
Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study. Pituitary (2014) 0.76
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol (2005) 5.19
Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA (2002) 4.38
Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry (2000) 3.89
Compulsive buying: descriptive characteristics and psychiatric comorbidity. J Clin Psychiatry (1994) 3.35
Taking chances: problem gamblers and mental health disorders--results from the St. Louis Epidemiologic Catchment Area Study. Am J Public Health (1998) 3.08
An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines. Neurology (2001) 2.20
Impulse control disorders in adult psychiatric inpatients. Am J Psychiatry (2005) 2.09
Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord (2005) 1.81
Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology (2003) 1.80
Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment? Mov Disord (2000) 1.77
Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease. Mov Disord (2003) 1.58
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord (2008) 9.52
Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA (2009) 8.40
Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry (2003) 7.11
Can food be addictive? Public health and policy implications. Addiction (2011) 6.27
Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med (2007) 5.68
Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med (2010) 5.27
Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol (2010) 4.77
Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Neuron (2002) 4.77
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord (2007) 3.86
Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers. Drug Alcohol Depend (2006) 3.61
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol (2007) 3.55
Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology (2012) 3.46
Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet (2003) 3.39
Compulsive features in behavioural addictions: the case of pathological gambling. Addiction (2011) 3.28
Introduction to behavioral addictions. Am J Drug Alcohol Abuse (2010) 3.22
Facial emotion perception in schizophrenia: a meta-analytic review. Schizophr Bull (2009) 2.98
Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet (2002) 2.90
The effect of a primary care practice-based depression intervention on mortality in older adults: a randomized trial. Ann Intern Med (2007) 2.84
Dementia with Lewy bodies. Lancet Neurol (2004) 2.66
The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology (2009) 2.62
Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology (2009) 2.60
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol (2009) 2.60
An odor-specific threshold deficit implicates abnormal intracellular cyclic AMP signaling in schizophrenia. Am J Psychiatry (2008) 2.53
Mindfulness-based treatments for co-occurring depression and substance use disorders: what can we learn from the brain? Addiction (2010) 2.50
Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry (2006) 2.50
Preliminary validity and reliability testing of a structured clinical interview for pathological gambling. Psychiatry Res (2004) 2.35
Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology (2006) 2.32
Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders. Pediatrics (2008) 2.32
Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's disease. Mov Disord (2014) 2.30
Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease. Am J Geriatr Psychiatry (2006) 2.26
Diabetes, depression, and death: a randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT). Diabetes Care (2007) 2.23
The neurobiology and genetics of impulse control disorders: relationships to drug addictions. Biochem Pharmacol (2007) 2.22
Individuals family history positive for alcoholism show functional magnetic resonance imaging differences in reward sensitivity that are related to impulsivity factors. Biol Psychiatry (2010) 2.16
Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging. Alzheimers Dement (2012) 2.13
Broadening our horizon: response to commentaries. Addiction (2012) 2.11
Neuropathologic substrates of Parkinson disease dementia. Ann Neurol (2012) 2.10
Impulse control disorders in adult psychiatric inpatients. Am J Psychiatry (2005) 2.09
Health correlates of recreational gambling in older adults. Am J Psychiatry (2004) 2.08
Pretreatment brain activation during stroop task is associated with outcomes in cocaine-dependent patients. Biol Psychiatry (2008) 2.04
Gender differences in the associations between past-year gambling problems and psychiatric disorders. Soc Psychiatry Psychiatr Epidemiol (2007) 2.02
Parkin mutations and susceptibility alleles in late-onset Parkinson's disease. Ann Neurol (2003) 2.01
Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. J Am Geriatr Soc (2004) 2.00
Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score. J Am Geriatr Soc (2008) 1.92
Long term effect of depression care management on mortality in older adults: follow-up of cluster randomized clinical trial in primary care. BMJ (2013) 1.91
Investigating the behavioral and self-report constructs of impulsivity domains using principal component analysis. Behav Pharmacol (2009) 1.90
Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord (2009) 1.89
Risk factors for fluconazole-resistant Candida glabrata bloodstream infections. Arch Intern Med (2009) 1.86
Evaluation of alpha-synuclein immunohistochemical methods used by invited experts. Acta Neuropathol (2008) 1.81
Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity. Psychopharmacology (Berl) (2011) 1.77
Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study. Ann Neurol (2010) 1.77
Problematic Internet use: clinical implications. CNS Spectr (2007) 1.74
Impulse control disorders in Parkinson disease: a multicenter case--control study. Ann Neurol (2011) 1.73
Recognition and treatment of depression in Parkinson's disease. J Geriatr Psychiatry Neurol (2003) 1.71
An FMRI study of the effects of psychostimulants on default-mode processing during Stroop task performance in youths with ADHD. Am J Psychiatry (2009) 1.70
Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease. Neurology (2012) 1.69
Psychiatric correlates of gambling in adolescents and young adults grouped by age at gambling onset. Arch Gen Psychiatry (2004) 1.68
Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood (2004) 1.66
Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: a randomized controlled trial. Ann Fam Med (2012) 1.64
Mindfulness training and stress reactivity in substance abuse: results from a randomized, controlled stage I pilot study. Subst Abus (2009) 1.62
Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology (Berl) (2009) 1.62
Depression, cardiovascular disease, diabetes, and two-year mortality among older, primary-care patients. Am J Geriatr Psychiatry (2005) 1.62
Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study. Mov Disord (2012) 1.60
The neurobiology of substance and behavioral addictions. CNS Spectr (2006) 1.59
Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease. Mov Disord (2011) 1.57
Neurodevelopment, impulsivity, and adolescent gambling. J Gambl Stud (2003) 1.57
The Penn Conditional Exclusion Test: a new measure of executive-function with alternate forms of repeat administration. Arch Clin Neuropsychol (2004) 1.57
Video-gaming among high school students: health correlates, gender differences, and problematic gaming. Pediatrics (2010) 1.56
Gender differences in adolescent gambling. Ann Clin Psychiatry (2006) 1.51
An initial study of neural responses to monetary incentives as related to treatment outcome in cocaine dependence. Biol Psychiatry (2011) 1.50
Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. J Neurosurg (2003) 1.49
Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism Relat Disord (2008) 1.49
A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia. Biol Psychiatry (2007) 1.48
Patient ethnicity and the identification and active management of depression in late life. Arch Intern Med (2005) 1.47
Shared brain vulnerabilities open the way for nonsubstance addictions: carving addiction at a new joint? Ann N Y Acad Sci (2010) 1.46
The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study. Psychiatry Res (2009) 1.46
Diminished frontostriatal activity during processing of monetary rewards and losses in pathological gambling. Biol Psychiatry (2012) 1.44
Stealing among high school students: prevalence and clinical correlates. J Am Acad Psychiatry Law (2011) 1.43
Gender differences in adolescent marijuana use and associated psychosocial characteristics. J Addict Med (2011) 1.42
Olanzapine treatment of corticosteroid-induced mood disorders. Psychosomatics (2002) 1.38
Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. Arch Neurol (2010) 1.38
Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) (2006) 1.38